VERICEL CORPORATION (VCEL) FY2026 Q2 P&L / Income Statement

VERICEL CORPORATION (VCEL) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and Service by Contract with Customer, Sales Channel. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

77,457,000 US dollars

Cost of product sales

21,055,000 US dollars

Gross profit

56,402,000 US dollars

Total operating expenses

55,968,000 US dollars

Income (loss) from operations

434,000 US dollars

Total other income

1,772,000 US dollars

Income before income taxes (calculated)

2,206,000 US dollars

Net income (loss)

2,206,000 US dollars

M A C I Implants and kits

65,506,000 US dollars

Biopsy kits - Directly to consumer

614,000 US dollars

Epicel - Directly to consumer

10,404,000 US dollars

Undisclosed (calculated)

933,000 US dollars

Selling, general and administrative

48,475,000 US dollars

Research and development

7,493,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.